Evidence map›Paper›PMID 36033822›Full record

ArticleFrontiers in public health2022

Transmissibility, hospitalization, and intensive care admissions due to omicron compared to delta variants of SARS-CoV-2 in Catalonia: A cohort study and ecological analysis.

Martí Català, Ermengol Coma, Sergio Alonso, Cristina Andrés, Ignacio Blanco, Andrés Antón, Antoni E Bordoy, Pere-Joan Cardona, Francesc Fina, Elisa Martró and 6 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019-positive patients.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023
    Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

Martí CatalàNuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, United Kingdom.
Ermengol ComaPrimary Care Services Information System (SISAP), Institut Català de la Salut (ICS), Barcelona, Spain.
Sergio AlonsoPhysics Department, Universitat Politècnica de Catalunya, Barcelona, Spain.
Cristina AndrésRespiratory Viruses Unit, Virology Section, Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Ignacio BlancoClinical Genetics Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol, Institut Universitari Germans Trias i Pujol (IGTP), Badalona, Spain.
Andrés AntónRespiratory Viruses Unit, Virology Section, Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Antoni E BordoyBiomedical Research Networking Center in Infectious Diseases CIBERINF, Instituto de Salud Carlos III, Madrid, Spain.
Pere-Joan CardonaBiomedical Research Networking Center in Infectious Diseases CIBERINF, Instituto de Salud Carlos III, Madrid, Spain.
Francesc FinaPrimary Care Services Information System (SISAP), Institut Català de la Salut (ICS), Barcelona, Spain.
Elisa MartróBiomedical Research Networking Center in Infectious Diseases CIBERINF, Instituto de Salud Carlos III, Madrid, Spain.
Manuel MedinaPrimary Care Services Information System (SISAP), Institut Català de la Salut (ICS), Barcelona, Spain.
Núria MoraPrimary Care Services Information System (SISAP), Institut Català de la Salut (ICS), Barcelona, Spain.
Verónica SaludesBiomedical Research Networking Center in Infectious Diseases CIBERINF, Instituto de Salud Carlos III, Madrid, Spain.
Clara PratsPhysics Department, Universitat Politècnica de Catalunya, Barcelona, Spain.
Daniel Prieto-AlhambraNuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, United Kingdom.
Enrique Alvarez-LacallePhysics Department, Universitat Politècnica de Catalunya, Barcelona, Spain.
Institut Català de la Salut · ESUniversitat Politècnica de Catalunya · ESHospital Universitari Germans Trias i Pujol · ESInstituto de Salud Carlos III · ESUniversitat Autònoma de Barcelona · ESNuffield Orthopaedic Centre · GBUniversity of Oxford · GBVall d'Hebron Institut de Recerca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: We aim to compare the severity of infections between omicron and delta variants in 609,352 SARS-CoV-2 positive cases using local hospitalization, vaccination, and variants data from the Catalan Health Care System (which covers around 7. 8 million people). Methods: We performed a substitution model to establish the increase in transmissibility of omicron using variant screening data from primary care practices (PCP) and hospital admissions. In addition, we used this data from PCP to establish the two periods when delta and omicron were, respectively, dominant (above 95% of cases). After that, we performed a population-based cohort analysis to calculate the rates of hospital and intensive care unit (ICU) admissions for both periods and to estimate reduction in severity. Rate ratios (RR) and 95% confidence intervals (95% CI) were calculated and stratified by age and vaccination status. In a second analysis, the differential substitution model in primary care vs. hospitals allowed us to obtain a population-level average change in severity. Results: We have included 48,874 cases during the delta period and 560,658 during the omicron period. During the delta period, on average, 3.8% of the detected cases required hospitalization for COVID-19. This percentage dropped to 0.9% with omicron [RR of 0.46 (95% CI: 0.43 to 0.49)]. For ICU admissions, it dropped from 0.8 to 0.1% [RR 0.25 (95% CI: 0.21 to 0.28)]. The proportion of cases hospitalized or admitted to ICU was lower in the vaccinated groups, independently of the variant. Omicron was associated with a reduction in risk of admission to hospital and ICU in all age and vaccination status strata. The differential substitution models showed an average RR between 0.19 and 0.50. Conclusion: Both independent methods consistently show an important decrease in severity for omicron relative to delta. The systematic reduction happens regardless of age. The severity is also reduced for non-vaccinated and vaccinated groups, but it remains always higher in the non-vaccinated population. This suggests an overall reduction in severity, which could be intrinsic to the omicron variant. The fact is that the RR in ICU admission is systematically smaller than in hospitalization points in the same direction.

Indexed as

COVID-19SARS-CoV-2Cohort StudiesCritical CareHospitalizationHumansSpaincohortsCOVID-19ecological studyseverityseverity and vaccination statussubstitution model

Identifiers

PMID36033822
PMCPMC9412031
OpenAlexW4291148459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.